Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Aclaris Therapeutics, Inc. | acrs-20171231ex321ab80e7.htm |
| EX-31.2 - EX-31.2 - Aclaris Therapeutics, Inc. | acrs-20171231ex312d050a6.htm |
| EX-31.1 - EX-31.1 - Aclaris Therapeutics, Inc. | acrs-20171231ex3118e0cd2.htm |
| EX-23.1 - EX-23.1 - Aclaris Therapeutics, Inc. | acrs-20171231ex2314a3db9.htm |
| 10-K - 10-K - Aclaris Therapeutics, Inc. | acrs-20171231x10k.htm |
Exhibit 21.1
Subsidiaries of Aclaris Therapeutics, Inc.
|
Name of Subsidiary |
|
Jurisdiction of Incorporation or |
|
|
|
|
|
Aclaris Therapeutics International, Ltd. |
|
United Kingdom |
|
Vixen Pharmaceuticals, Inc. |
|
Delaware |
|
Confluence Life Sciences, Inc. |
|
Delaware |